1. Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease
    Xiangwei Song et al, 2022, Frontiers in Aging Neuroscience CrossRef
  2. Liraglutide ameliorates diabetes-associated cognitive dysfunction via rescuing autophagic flux
    Meng Zhang et al, 2021, Journal of Pharmacological Sciences CrossRef
  3. Exendin‐4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease
    Aanchal Verma et al, 2024, Chemical Biology & Drug Design CrossRef
  4. Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer’s disease models: a systematic review and meta-analysis of preclinical studies
    Fanjing Kong et al, 2023, Frontiers in Pharmacology CrossRef
  5. Potential new therapeutic target for Alzheimer's disease: Glucagon‐like peptide‐1
    Xiao‐Yu Liu et al, 2021, European Journal of Neuroscience CrossRef
  6. GLP-1 agonist Liraglutide prevents MK‑801–induced schizophrenia‑like behaviors and BDNF, CREB, p-CREB, Trk-B expressions in the hippocampus and prefrontal cortex in Balb/c mice
    Meltem Donmez Kutlu et al, 2023, Behavioural Brain Research CrossRef
  7. Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus
    A Young Sim et al, 2021, Frontiers in Neuroscience CrossRef
  8. GLP-1’s role in neuroprotection: a systematic review
    Damla Erbil et al, 2019, Brain Injury CrossRef
  9. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey Cummings et al, 2022, European Journal of Neuroscience CrossRef
  10. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
    Haiyang Du et al, 2022, Frontiers in Endocrinology CrossRef
  11. Effect of DPP-4 inhibitor on elderly patients with T2DM combined with MCI
    Jujun Xue et al, 2019, Experimental and Therapeutic Medicine CrossRef
  12. Exendin-4 attenuates brain mitochondrial toxicity through PI3K/Akt-dependent pathway in amyloid beta (1–42)-induced cognitive deficit rats
    Debapriya Garabadu et al, 2019, Neurochemistry International CrossRef
  13. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
    Mei Zhou et al, 2019, Biochemical and Biophysical Research Communications CrossRef
  14. DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
    Shuyi Chen et al, 2019, Neuropharmacology CrossRef
  15. Gastrointestinal hormones in regulation of memory
    Anwesha Mandal et al, 2018, Peptides CrossRef
  16. Aβ1–42 oligomer induces alteration of tight junction scaffold proteins via RAGE-mediated autophagy in bEnd.3 cells
    Yuanjin Chan et al, 2018, Experimental Cell Research CrossRef
  17. Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease
    Syed Obaidur Rahman et al, 2020, European Journal of Pharmacology CrossRef
  18. Microcurrent therapy as the nonpharmacological new protocol against Alzheimer’s disease
    Eun Ho Kim et al, 2024, Frontiers in Aging Neuroscience CrossRef
  19. The Emerging Role of GLP-1 Receptors in DNA Repair: Implications in Neurological Disorders
    Jenq-Lin Yang et al, 2017, International Journal of Molecular Sciences CrossRef
  20. Critical Review of the Alzheimer’s Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    Julio A. Flores-Cuadra et al, 2021, Journal of Alzheimer's Disease CrossRef
  21. Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in Alzheimer’s disease
    Mingcui Zheng et al, 2021, 3 Biotech CrossRef
  22. Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review
    Benjamin Kioussis et al, 2021, Ageing Research Reviews CrossRef
  23. Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease
    Adriana M. Zago et al, 2024, Molecular Neurobiology CrossRef